Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has disclosed its schedule of meetings with analysts and institutional investors from June 18 to June 20, 2025, as required under SEBI's Listing Regulations. On June 18, the company will hold a one-on-one meeting with Birla Mutual Fund. On June 19, a group meeting is planned with Jefferies, Mahindra Manulife, DT Investment Management, Quantum AMC, Prajana Advisors, and CWC Advisors. On June 20, a one-on-one meeting is scheduled with global hedge fund Point 72. The filing notes that the schedule is subject to change due to unforeseen circumstances.
This is a routine regulatory disclosure and is unlikely to move the stock on its own. However, meetings with prominent global investors like Point 72 and brokerages like Jefferies may signal ongoing investor engagement, which shareholders can watch for any incremental updates.